Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Anatomic Stage I Breast Cancer AJCC v8 2 Sarcoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Heart Failure 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Advanced Breast Carcinoma 1

Interventions

Echocardiography 4 sacubitril and valsartan sodium hydrate drug combination 3 Standard of Care 3 Nutrition Assessment 3 Exercise 3 Electrocardiography 3 Carvedilol 3 dapagliflozin 2 Surveys and Questionnaires 2 Spironolactone 2 Ivabradine 2 Blood Specimen Collection 2 Atorvastatin 2 ziprasidone 1 pertuzumab 1 pegfilgrastim 1 nicotinamide-beta-riboside 1 empagliflozin 1 candesartan 1 Zolpidem 1 Watchful Waiting 1 Warfarin 1 Vincristine 1 Vecuronium Bromide 1 Vascular Stiffness 1 Vancomycin 1 Valsartan 1 Trastuzumab 1 Tranexamic Acid 1 Tobramycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Heart Failure × Ogivri × Clear all

NCT04680442 2025-04-06

SCHOLAR-2

Population Health Research Institute

Phase 2 Recruiting

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡